Page 371 - FINAL PROGRAMME 2017

SPONSORSHIP ACKNOWLEDGEMENTS
Company sessions are held in Room V, symposia in Plenary 1
Monday 03 July 2017
11:45 - 13:00: Industry sponsored symposium: Ferring
Personalising ovarian stimulation: Challenging the status quo
Chairs
Jan-Steffen Krüssel, Germany Laura Francesca Rienzi, Italy
Welcome and introduction
Jan-Steffen Krüssel, Germany Laura Francesca Rienzi, Italy
Pushing the envelope: Risks and rewards of high oocyte yield
Scott Nelson, United Kingdom
Personalisation in our hands: How far can we go today?
Christophe Blockeel, Belgium
Putting individualisation into practice: Experience with follitropin delta
Ernesto Bosch, Spain
Closing remarks
Jan-Steffen Krüssel, Germany Laura Francesca Rienzi, Italy
13:00 - 14:00: Industry sponsored session: AYTU BioScience 14:00 - 15:15: Industry sponsored symposium: IBSA
14:00 - 14:05 14:05 - 14:25
14:25 - 14:45 14:45 - 15:05 15:05 - 15:15
Natural diversity in ART outcome
Chairs
Dominique De Ziegler, France Claus Andersen Yding, Denmark
Welcome and introduction
Precision medicine: assess FSH and LH receptor polymorphism
Yvonne L. Lundberg Giwercman, Sweden
Ethnical diversity in COS responses and implantation rates
Valerie Baker, U.S.A.
Empowering COS: matching expectations and yields
Renato Fanchin, France
Conclusions
16:00 - 17:00: Industry sponsored session: Lo.Li.Pharma
Insulin sensitizers and PCOS: Physiology and therapeutic use of inositols
Chair
S. Benvenga, Italy John E. Nestler, U.S.A.
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 371
ACKNOWLEDGEMENTS